Announcements Trials

Browse Landscape

Phase

Status

Completed 51 Unknown 13 Terminated 9 Active not recruiting 4 Withdrawn 3 Recruiting 3 Approved for marketing 3 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Pemetrexed 2 trilaciclib 1 trastuzumab deruxtecan 1 pembrolizumab 1 olaparib 1 lorlatinib 1 durvalumab 1 aumolertinib 1 apatinib 1 Standard of Care 1 Saline Solution 1 Radiosurgery 1 Patient Navigation 1 Observation 1 Interviews as Topic 1 Gemcitabine 1 Drug Delivery Systems 1 Cisplatin 1 Carboplatin 1 Biopsy, Fine-Needle 1 Anterior Temporal Lobectomy 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Afatinib × Thoracic × Clear all

NCT06759857 2025-01-06

FHND9041

Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.

Phase 3 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡